Status:
UNKNOWN
Pure Florid and Pleomorphic Lobular Carcinoma in Situ of the Breast: Towards an Increasingly Uniform Management
Lead Sponsor:
Istituto Oncologico Veneto IRCCS
Conditions:
Pleomorphic Lobular Breast Carcinoma in Situ
Breast Florid Lobular Carcinoma in Situ
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this retrospective multicenter observational study is to understand and evaluate the diagnostic and therapeutic management of pure forms of Florid Lobular Carcinoma In Situ (FLCIS) and Ple...
Detailed Description
Classical lobular carcinoma in situ (CLCIS) of the breast is considered a non-obligate precursor of invasive carcinoma. Histologically, it is categorized as a lesion with uncertain malignancy potentia...
Eligibility Criteria
Inclusion
- Histologic diagnosis of PLCIS and/or FLCIS of the breast on both core-biopsy and/or on final specimen histology;
- Aged 18 years or older.
Exclusion
- Histologic diagnosis of CLCIS;
- Histologic diagnosis of LCIS (any type) associated with invasive carcinoma
Key Trial Info
Start Date :
October 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2024
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06133465
Start Date
October 15 2023
End Date
July 31 2024
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Oncologico Veneto IRCCS
Padua, Italy, 35168